Mastercard, Inc
22 Haziran 2021
Stock Market Data
22 Haziran 2021

So be sure to compare it to its group when comparing stocks in different industries. Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers.

  • It raised the lower end of its earnings guidance by $0.05 to now be in the range of $6.30 and $6.45 on a per share and adjusted basis.
  • A stock with a P/E ratio of 20, for example, is said to be trading at 20 times its annual earnings.
  • However, we think that Pfizer’s PFE Q2 results were great, and it didn’t warrant a decline post the earnings announcement.
  • And, of course, the 4 week change helps put the 1 week change into context.
  • What if you’re looking for a more balanced portfolio instead?

Arena has a robust drug pipeline focused on immunology drugs. One of the late-stage candidates – Etrasimod – is used to treat ulcerative colitis, Crohn’s disease, and eosinophilic esophagitis, and its potential peak sales are estimated to top $2.5 billion. Data are provided ‘as is’ for informational purposes only and are not intended for trading purposes. Data may be intentionally delayed pursuant to supplier requirements. Get a sense of people’s overall feelings towards a company in social media with this summary tool.

Pfizer Jumps Ahead In Crowded Race For Lucrative Rsv Vaccine

Once again, cash flow is net income plus depreciation and other non-cash charges. A higher number means the company has more debt to PFE stock price equity, whereas a lower number means it has less debt to equity. A D/E ratio of 1 means its debt is equivalent to its common equity.

PFE stock

The Company is engaged in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 to -2 . This is a lower news sentiment than the 0.80 average news sentiment score of Medical companies. Goldman Sachs analyst Chris Shibutani maintained a Hold rating on Pfizer (PFE – Research Report) today and set a price target of $50.00. The company’s shares closed yesterday at $47.90.Shibutani covers the Healthcare secto… In a report released today, Carter Gould from Barclays maintained a Hold rating on Pfizer (PFE – Research Report), with a price target of $50.00. The company’s shares closed yesterday at $47.90.According to TipRanks, Gould…

Analyst Ratings

A strong weekly advance is a sought after metric for putting potential momentum stocks onto one’s radar. Others will look for a pullback on the week as a good entry point, assuming the longer-term price changes (4 week, 12 weeks, etc.) are strong. Note; companies will typically sell for more than their book value in much the same way that a company will sell at a multiple of its earnings.

PFE stock

Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Pfizer Inc. said Thursday a Phase 3 trial of older adults testing its bivalent RSV vaccine candidate achieved 85.7% efficacy dotbig in participants with more severe disease. The lithium market will grow nearly 4X over the next 8 years, from the 320,000 metric tons mined last year, to 1.4 million metric tons by 2030.

Pfizer Marketrank Forecast

A sales/assets ratio of 2.50 means the company generated $2.50 in revenue for every $1.00 of assets on its books. Projected EPS Growth looks at the estimated growth rate for one year. It takes the consensus estimate for the current fiscal year divided by the EPS for the last completed fiscal year .

MarketBeat has tracked 7 reddit mentions for Pfizer this week, compared to 21 mentions on an average week. Short interest in Pfizer has recently increased by 13.42%, indicating that investor sentiment is decreasing significantly.

Could This Move By Moderna Cost Pfizer Billions?

Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth. Please note you can display only one indicator at a time in this view. Please use Advanced Chart if you want to display more than one. Learn how to evaluate a company’s dotbig review health with our Fundamental Analysis education. The VGM score is based on the trading styles of Growth, VAlue, and Momentum. For example, a regional bank would be classified in the Finance Sector. Within the Finance Sector, it would fall into the M Industry of Banks & Thrifts.

You will find other valuable comparisons for companies across industries at Peer Comparisons. Pfizer has also announced its plans to acquire Biohaven Pharmaceutical, a company specializing in migraine treatments, in a deal valued at about $11.6 billion. The peak sales potential of Biohaven’s portfolio is estimated to top $6 billion. These deals will bode Forex news well for Pfizer in the long run, as the contribution from the Covid-19 vaccine and antiviral pills decline in the coming years. However, we think that Pfizer’s PFE Q2 results were great, and it didn’t warrant a decline post the earnings announcement. Some of the company’s non-Covid products, such as Eliquis and Prevnar, are seeing a rebound in demand.

At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation dotbig website of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.41% per year. These returns cover a period from January 1, 1988 through July 4, 2022.

Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green. Our valuation is based on a forward P/E ratio of around 9x based on our earnings forecast of $6.56 on a per-share basis for full-year 2022. At its current levels, is trading at under 8x its forward earnings, compared to the last three-year average of 10x ZRX , implying more room for growth.

The ex-dividend date of this dividend is Thursday, July 28th. Pfizer’s stock was trading at $59.05 at the beginning of 2022.

Bir cevap yazın

E-posta hesabınız yayımlanmayacak.

Görüşme Başlat
Size nasıl yardımcı olabiliriz.
Umay Otomotiv
Size nasıl yardımcı olabiliriz.